Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/19/2005CN1684940A Manufacturing process for NO-donating compounds such as NO-donating diclofenac
10/19/2005CN1684738A Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
10/19/2005CN1684709A Medicine carrier for local application
10/19/2005CN1684708A Anti-NGF antibodies for the treatment of various disorders
10/19/2005CN1684701A Ophthalmologic irrigation solutions and method
10/19/2005CN1684697A Coixenolide soft capsule for treating prostatic disease
10/19/2005CN1684696A Oral and dental composition
10/19/2005CN1684695A Vitreoretinal tamponades based on fluorosilicone fluids
10/19/2005CN1684694A Inhibition of protein kinase C alpha for treatment of diabetes mellitus and cardiovascular diseases
10/19/2005CN1684693A Boronic acid polyvalent salts for treating thrombosis
10/19/2005CN1684692A External preparation for inhibiting keloid formation
10/19/2005CN1684691A Formulation for lipophilic agents
10/19/2005CN1684690A 17beta-estradiol/levonorgestrel transderm patch for hormone replacement therapy
10/19/2005CN1684689A Glaucoma-treating agent consisting of RHo kinase inhibitor and prostaglandin
10/19/2005CN1684688A Stable eye lotion containing latanoprost as active ingredient
10/19/2005CN1684687A Modified release formulations of oxcarbazepine and derivatives thereof
10/19/2005CN1684686A Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
10/19/2005CN1684685A Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications
10/19/2005CN1684684A Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes
10/19/2005CN1684683A Potent inhibitor of HCV serine protease
10/19/2005CN1684682A Small organic molecules that increase the activity of gelatinase A in ocular cells
10/19/2005CN1684681A Bicifadine formulation
10/19/2005CN1684679A Preventive or remedy for bedsore
10/19/2005CN1684677A Composition containing arachidonic acid or the combination of docosahexenoic acid therewith for enhancing cognitive abilities
10/19/2005CN1684676A Leucine-enriched nutritional compositions
10/19/2005CN1684675A A composition comprising phytospingosine derivatives for apoptosis induction
10/19/2005CN1684674A Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1684670A Methods and dosage forms for controlled delivery of paliperidone
10/19/2005CN1684669A Compositions comprising HMG-CoA reductase inhibitor
10/19/2005CN1684668A Sustained release delivery of amphetamine salts
10/19/2005CN1684667A Storage stable tablets of fosinopril sodium
10/19/2005CN1684665A Solid pharmaceutical formulations comprising telmisartan
10/19/2005CN1684664A Injectable growth promoting and anthelmintic composition
10/19/2005CN1684662A Cleansing composition containing antifungal agent and antibacterial agent
10/19/2005CN1684641A Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device
10/19/2005CN1684585A Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid
10/19/2005CN1683546A Nianzhou Strain and its use
10/19/2005CN1683525A Method for changing IL-2 receptor distribution in T cell film micro area and its use
10/19/2005CN1683441A Process for preparing biologically degradable reverse temperature sensitive material
10/19/2005CN1683418A Process for preparing antrodia camphorata polysaccharide and antrodia camphorata triterpene with micro-prorous adsorptive resin and its product
10/19/2005CN1683386A Method for extracting vitexin, use and preparation
10/19/2005CN1683385A Ibuprofen sugar derivative and its preparing process and use
10/19/2005CN1683381A Trifolium pratense extract and preparing method
10/19/2005CN1683379A Novel liposoluble platinum (II) anti-tumor ligand
10/19/2005CN1683374A Indole carbazole alkaloid and its preparing method and use
10/19/2005CN1683373A Thiophenopyridine substituted acetyl hyarazine derivative
10/19/2005CN1683371A Substituted purine and substituted 1, 2, 3-trizole pyrimidine new compound with anti-HIV activity, rpeparing method and use
10/19/2005CN1683369A S-omeprazole zinc salt and its preparing method and use
10/19/2005CN1683367A Process for preparing lansoprazole sodium salt
10/19/2005CN1683366A Fatty chain end group diamine substituted hypocrellin derivative and its preparing method and use
10/19/2005CN1683365A Substituted dioxopentacyclic derivative and its use in preparing neuro regulator
10/19/2005CN1683354A 4-hydroxy pyrone compounds with anti-HIV activity, preparing method and use
10/19/2005CN1683347A Substituted aryl methylene sulfonylated aza cyclo-pentanone compounds, its medicine compositions and its preparing process and use
10/19/2005CN1683345A Acid salt for synergistic medicine of chuanqiongzine and its preparing method
10/19/2005CN1683344A 4-quinazolone derivative and its use in anti-tumor medicine
10/19/2005CN1683343A Novel method of synthesising 1, 3, 4, 5-tetrahydro-2H-3-benzazepin-2-one derivatives and use thereof in the synthesis of ivabradine and the salts thereof for addition to a pharmaceutically acceptable aci
10/19/2005CN1683341A New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
10/19/2005CN1683340A 2-nitro-gen-dicyclic [2, 2, 1] hepta-5-ene-3-carboxylic derivative and its use preparing neuro regulator
10/19/2005CN1683339A 7-substituted-8-methoxy fluoroquinolone carboxylic derivatives, preparing process, preparation and use thereof
10/19/2005CN1683317A Ester compound of thymol and/or carvacrol, preparing method and its medicinal active composition
10/19/2005CN1683303A Novel use of 3, 4-dihydroxy-benzene formaldehyde and its derivatives in treating hypatitis B and virus infectious diseases
10/19/2005CN1683299A Metabolites of ecteinascidin 743
10/19/2005CN1683012A Ginsenoside nano microparticle and its preparing method and use
10/19/2005CN1682763A Method for extracting bone calcium from animal bone powder
10/19/2005CN1682759A Health article useful for preventing and treating cardiovascular diseases
10/19/2005CN1682755A Material for treating inflammation and pain
10/19/2005CN1682754A Ginseng-gaboderma lucidum tranquilizing dripping pill and its preparing method
10/19/2005CN1682753A Paeonal injection emulsion for anti-tumor and its preparing method
10/19/2005CN1682752A Process for preparing lentinan drip liquid
10/19/2005CN1682751A Agaric polysaccharide freeze-dried powder injection and its preparing method
10/19/2005CN1682750A Disodium adenosine triphosphate solid composition for injection and its preparing method
10/19/2005CN1682749A Flavone composition for sobering and liver protection and its use
10/19/2005CN1682748A Chinese medicine preparation for treating rheumatism and preparation and use
10/19/2005CN1682747A Use of panaxadiol group saponin in preparing anti-shock medicine
10/19/2005CN1682746A Use of clasping gutweed flavonoid in preparing medicine for treating coronary heart disease
10/19/2005CN1682745A Nano capsule containing glycyrrhizic acid medicine and its preparing method
10/19/2005CN1682744A Method for preparing asiaticoside cataplasm
10/19/2005CN1682743A Pharmaceutical formulations
10/19/2005CN1682742A Use of 23-hydroxy betulic acid in inhibiting blood vessel formation
10/19/2005CN1682741A Anti-cancer medicine 23-hydroxy betulic acid fat emulsion and its preparing method
10/19/2005CN1682740A Use of pentacylic triterpene compounds in preparing glycogenic phosphorylase inhibitor
10/19/2005CN1682739A Cefadroxil dry suspension and preparing method
10/19/2005CN1682738A Spray containing molsidomine
10/19/2005CN1682737A Compound dimethylbiguanide/glipizide control release tablet and preparing method
10/19/2005CN1682736A Gatifloxacin lactate injection and its preparing method
10/19/2005CN1682735A Soft capsule containing flunarizine
10/19/2005CN1682734A Oral disintegration tablet of dihydroergotoxine and its derivatives and its preparing process
10/19/2005CN1682733A Anti-cancer analgetic preparation
10/19/2005CN1682732A Medicinal composition having antiseptic and anti-inflammatory function
10/19/2005CN1682731A Medicine having anti-infection and analgetic function
10/19/2005CN1682730A Cepharanthine slow releasing preparation
10/19/2005CN1682729A Fibrauretin dripping pill and its preparing method
10/19/2005CN1682728A Stable palonosetron injection
10/19/2005CN1682727A Freeze-dried preparation containing balofloxacin and its use
10/19/2005CN1682726A Inclusion containing raltitrexed and preparation
10/19/2005CN1682725A Inclusion containing raltitrexed and its powder injection
10/19/2005CN1682724A Oral treating agent for treating chronic obstructive disease of lung (COPD) containing ipratropium bromide and salbutamol
10/19/2005CN1682723A Scopolamine hydrobromide dry powder inhalant for nose and preparing method
10/19/2005CN1682722A New use of chlophenamine maleate
1 ... 4501 4502 4503 4504 4505 4506 4507 4508 4509 4510 4511 4512 4513 4514 4515 4516 4517 4518 4519 4520 4521 ... 7860